EdgarLookup

LIGAND PHARMACEUTICALS INC — All Filings

1,000 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 144 144/A 15-12G 3 3/A 4 4/A 424B1 424B3 424B5 425 5 8-A12B 8-A12G 8-A12G/A 8-K 8-K/A ARS CORRESP CT ORDER D DEF 14A DEFA14A DEFM14A DEFN14A DFAN14A EFFECT NT 10-K NT 10-Q POS AM PRE 14A PREM14A PREN14A PRER14A S-1 S-1/A S-3 S-3/A S-3ASR S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13E3 SC 13E3/A SC 13E4 SC 13E4/A SC 13G SC 13G/A SC TO-C SC TO-T SC TO-T/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
4 PRIMARY DOCUMENT 0002001011-26-000035 Mar 27, 2026 Mar 2, 2026
4 PRIMARY DOCUMENT 0002001011-26-000033 Mar 27, 2026 Mar 2, 2026
4 PRIMARY DOCUMENT 0002001011-26-000032 Mar 27, 2026 Mar 2, 2026
SCHEDULE 13G/A 0000102909-26-001767 Mar 27, 2026
4 OWNERSHIP DOCUMENT 0001104659-26-034308 Mar 25, 2026 Mar 23, 2026
144 0001950047-26-002891 Mar 23, 2026
4 PRIMARY DOCUMENT 0002001011-26-000026 Mar 13, 2026 Mar 11, 2026
144 0001950047-26-002496 Mar 11, 2026
4 PRIMARY DOCUMENT 0002001011-26-000024 Mar 6, 2026 Mar 4, 2026
4 PRIMARY DOCUMENT 0002001011-26-000023 Mar 6, 2026 Mar 4, 2026
144 0001950047-26-002309 Mar 6, 2026
4 OWNERSHIP DOCUMENT 0001104659-26-023943 Mar 5, 2026 Mar 3, 2026
4 PRIMARY DOCUMENT 0002001011-26-000018 Mar 4, 2026 Mar 2, 2026
144 0001950047-26-002204 Mar 4, 2026
144 0001950047-26-002183 Mar 4, 2026
144 0001950047-26-002083 Mar 3, 2026
S-3ASR S-3ASR 0001193125-26-083241 Feb 27, 2026
10-K 10-K 0000886163-26-000006 Feb 27, 2026 Dec 31, 2025
8-K 8-K 0000886163-26-000003 Feb 26, 2026
4 PRIMARY DOCUMENT 0002001011-26-000013 Feb 18, 2026 Feb 14, 2026
4 PRIMARY DOCUMENT 0002001011-26-000012 Feb 18, 2026 Feb 14, 2026
4 PRIMARY DOCUMENT 0002001011-26-000011 Feb 18, 2026 Feb 14, 2026
4 PRIMARY DOCUMENT 0002001011-26-000007 Feb 4, 2026 Feb 2, 2026
144 0001969223-26-000093 Feb 2, 2026
4 PRIMARY DOCUMENT 0002001011-26-000004 Jan 6, 2026 Jan 2, 2026
4 PRIMARY DOCUMENT 0002001011-26-000003 Jan 6, 2026 Dec 31, 2025
144 0001969223-26-000006 Jan 2, 2026
4 4 0001193125-25-326891 Dec 19, 2025 Dec 17, 2025
4 PRIMARY DOCUMENT 0002001011-25-000127 Dec 18, 2025 Dec 16, 2025
8-K 8-K 0001193125-25-324830 Dec 18, 2025
4 PRIMARY DOCUMENT 0002001011-25-000125 Dec 16, 2025 Dec 12, 2025
144 0001950047-25-010259 Dec 12, 2025
4 PRIMARY DOCUMENT 0002001011-25-000123 Dec 9, 2025 Dec 5, 2025
4 PRIMARY DOCUMENT 0002001011-25-000122 Dec 8, 2025
4 PRIMARY DOCUMENT 0002001011-25-000121 Dec 8, 2025 Dec 4, 2025
4 PRIMARY DOCUMENT 0002001011-25-000113 Dec 3, 2025 Dec 1, 2025
144 0001969223-25-001008 Dec 1, 2025
SCHEDULE 13G/A 0001274173-25-000314 Nov 14, 2025
4 PRIMARY DOCUMENT 0002001011-25-000098 Nov 12, 2025 Nov 7, 2025
4 PRIMARY DOCUMENT 0002001011-25-000097 Nov 12, 2025 Nov 7, 2025
4 4 0001193125-25-274436 Nov 10, 2025 Nov 6, 2025
SCHEDULE 13D/A 0001193125-25-274432 Nov 10, 2025
144 0001950047-25-008580 Nov 7, 2025
144 0001950047-25-008546 Nov 7, 2025
10-Q 10-Q 0000886163-25-000063 Nov 7, 2025 Sep 30, 2025
8-K 8-K 0000886163-25-000058 Nov 6, 2025
4 PRIMARY DOCUMENT 0002001011-25-000096 Nov 5, 2025 Nov 3, 2025
144 0001969223-25-000902 Nov 3, 2025
SCHEDULE 13G/A 0002012383-25-002417 Oct 17, 2025
4 PRIMARY DOCUMENT 0002001011-25-000093 Oct 3, 2025 Oct 1, 2025